These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36479869)

  • 1. Emergency Department-Initiated Interventions for Illicit Drug Overdose: An Integrative Review of Best Practices.
    Mechling BM; Ahern N; Palumbo R; Bebawy A; Zumpe RL
    J Psychosoc Nurs Ment Health Serv; 2023 Jun; 61(6):18-24. PubMed ID: 36479869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of emergency department-initiated buprenorphine for opioid use disorder in a rural southern state.
    Bogan C; Jennings L; Haynes L; Barth K; Moreland A; Oros M; Goldsby S; Lane S; Funcell C; Brady K
    J Subst Abuse Treat; 2020 Mar; 112S():73-78. PubMed ID: 32220414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emergency Department as an Opportunity for Naloxone Distribution.
    Gunn AH; Smothers ZPW; Schramm-Sapyta N; Freiermuth CE; MacEachern M; Muzyk AJ
    West J Emerg Med; 2018 Nov; 19(6):1036-1042. PubMed ID: 30429939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative approach to harm reduction by managed care pharmacy team for populations with substance use disorder.
    Osibanjo O; Reinhardt R; Clemans S; Andoniadis S; Carson P; Benkstein K
    J Am Pharm Assoc (2003); 2023; 63(1):396-402. PubMed ID: 36564331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naloxone provision to emergency department patients recognized as high-risk for opioid use disorder.
    Lane BH; Lyons MS; Stolz U; Ancona RM; Ryan RJ; Freiermuth CE
    Am J Emerg Med; 2021 Feb; 40():173-176. PubMed ID: 33243535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A scoping review of post opioid-overdose interventions.
    Bagley SM; Schoenberger SF; Waye KM; Walley AY
    Prev Med; 2019 Nov; 128():105813. PubMed ID: 31437462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do electronic health record prompts increase take-home naloxone administration for emergency department patients after an opioid overdose?
    Marino R; Landau A; Lynch M; Callaway C; Suffoletto B
    Addiction; 2019 Sep; 114(9):1575-1581. PubMed ID: 31013394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid education and nasal naloxone rescue kits in the emergency department.
    Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
    West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose.
    Scheuermeyer FX; Grafstein E; Buxton J; Ahamad K; Lysyshyn M; DeVlaming S; Prinsloo G; Van Veen C; Kestler A; Gustafson R
    J Urban Health; 2019 Feb; 96(1):21-26. PubMed ID: 30324356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying barriers to emergency department-initiated buprenorphine: A spatial analysis of treatment facility access in Michigan.
    Dora-Laskey A; King A; Sadler R
    Am J Emerg Med; 2022 Jan; 51():393-396. PubMed ID: 34826787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic.
    Dadiomov D; Bolshakova M; Mikhaeilyan M; Trotzky-Sirr R
    Harm Reduct J; 2022 Jun; 19(1):69. PubMed ID: 35768817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for the design of overdose education and naloxone distribution interventions: results of a multi-stakeholder workshop.
    Sellen K; Markowitz B; Parsons JA; Leece P; Handford C; Goso N; Hopkins S; Klaiman M; Shahin R; Milos G; Wright A; Charles M; Morrison L; Strike C; Orkin A;
    BMC Public Health; 2023 May; 23(1):888. PubMed ID: 37189052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tele-buprenorphine for emergency department overdose visit follow up and treatment initiation.
    Wightman RS; Jacka B; Uber J; McKenzie M; Reddy NG; Winters R; Jordison Keeler LA; Samuels EA
    Am J Emerg Med; 2021 Dec; 50():409-412. PubMed ID: 34481260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone Administration in US Emergency Departments, 2000-2011.
    Frank JW; Levy C; Calcaterra SL; Hoppe JA; Binswanger IA
    J Med Toxicol; 2016 Jun; 12(2):148-56. PubMed ID: 26621354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
    D'Onofrio G; O'Connor PG; Pantalon MV; Chawarski MC; Busch SH; Owens PH; Bernstein SL; Fiellin DA
    JAMA; 2015 Apr; 313(16):1636-44. PubMed ID: 25919527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid dependence treatment, including buprenorphine/naloxone.
    Raisch DW; Fye CL; Boardman KD; Sather MR
    Ann Pharmacother; 2002 Feb; 36(2):312-21. PubMed ID: 11847954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
    Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
    Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal Authority for Emergency Medical Services to Increase Access to Buprenorphine Treatment for Opioid Use Disorder.
    Davis CS; Carr DH; Glenn MJ; Samuels EA
    Ann Emerg Med; 2021 Jul; 78(1):102-108. PubMed ID: 33781607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction.
    DiPaula BA; Cooke CE; Boyle CJ; Love RC
    J Am Pharm Assoc (2003); 2022; 62(1):241-246. PubMed ID: 34690080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.